Remus Pharmaceuticals Ltd (REMUS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: REMUS | Trading | Small Cap

BSE Share Price
Not Listed

Remus Pharmaceuticals Ltd (REMUS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: REMUS | Trading | Small Cap

DeciZen - make an informed investing decision on Remus Pharmaceutical

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Remus Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
39.68
Market Cap:
789.7 Cr.
52-wk low:
0
52-wk high:
0

Is Remus Pharmaceuticals Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Remus Pharmaceutical: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Remus Pharmaceuticals Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 47.8%48.8%93.1%68.8%24.9%13.5%-
Value Creation
Index
2.42.55.73.90.80.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 11.918.424.74563.979.279
Sales YoY Gr.-54.5%34.1%82.3%42%23.8%-
Adj EPS 0.81.14.19.313.816.416.9
YoY Gr.-35.7%259.7%126.6%48.2%18.7%-
BVPS (₹) 2.53.88.222.1130.6205.6210.6
Adj Net
Profit
0.70.93.38.116.219.320
Cash Flow from Ops. 1.32.855.36.315.6-
Debt/CF from Ops. 0.30.101.50.20.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA46%47.4%23.8%
Adj EPS NA81.1%58.6%18.7%
BVPSNA141%192.5%57.5%
Share Price - - - -73.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
33.23668.162.718.89.78.1
Op. Profit
Mgn %
3.34.116.723.432.832.8NAN
Net Profit
Mgn %
5.6513.317.925.424.325.1
Debt to
Equity
0.20.100.400-
Working Cap
Days
0132155791402320
Cash Conv.
Cycle
0-7-33-147300

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Remus Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 16.9 24.7
TTM Sales (₹ Cr.) 79.2 620
BVPS (₹.) 210.6 222.1
Reserves (₹ Cr.) 236 250
P/BV 3.18 3.02
PE 39.68 27.17
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 790
Equity (₹ Cr.) 11.8
Face Value (₹) 10
Industry PE 36.9

Management X-Ray of Remus Pharmaceutical:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Remus Pharmaceutical - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Remus Pharmaceutical

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales121825456479
Operating Expenses 121821344353
Manufacturing Costs001122
Material Costs71112212835
Employee Cost 333579
Other Costs 234676
Operating Profit 014112126
Operating Profit Margin (%) 3.3%4.1%16.7%23.4%32.8%32.8%
Other Income 111233
Interest 000000
Depreciation 000012
Exceptional Items 000000
Profit Before Tax 115112227
Tax 001367
Profit After Tax 11391720
PAT Margin (%) 6.8%5.6%13.9%18.9%26.0%25.1%
Adjusted EPS (₹)1.01.34.39.814.116.9
Dividend Payout Ratio (%)0%0%0%3%5%4%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 23719154242
Share Capital 001116
Reserves 23618152236
Minority Interest000000
Debt000812
Long Term Debt000712
Short Term Debt000100
Trade Payables155485
Others Liabilities 23442131
Total Liabilities 5111635183280

Fixed Assets

Gross Block1113711
Accumulated Depreciation000124
Net Fixed Assets 100357
CWIP 000000
Investments 00321127209
Inventories012022
Trade Receivables24351516
Cash Equivalents 1113114
Others Assets 25732442
Total Assets 5111635183280

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 1355616
PBT 115112227
Adjustment 00-00-10
Changes in Working Capital 022-3-9-4
Tax Paid -0-0-1-3-6-8
Cash Flow From Investing Activity -1-3-5-15-47-12
Capex -1-0-0-3-3-4
Net Investments 0-0-3-18-43-7
Others 0-3-15-1-2
Cash Flow From Financing Activity 0-0-01242-1
Net Proceeds from Shares 0004470
Net Proceeds from Borrowing 00-00-61
Interest Paid -0-0-0-0-0-0
Dividend Paid 0000-1-1
Others 0-0082-0
Net Cash Flow 1-00212

Finance Ratio

PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)40.1740.4971.3766.1419.2510.06
ROCE (%)47.7648.8493.1368.8224.9213.53
Asset Turnover Ratio2.262.261.841.790.590.34
PAT to CFO Conversion(x)131.670.560.350.8
Working Capital Days
Receivable Days505248315670
Inventory Days131620869
Payable Days68103146707769

Remus Pharmaceuticals Ltd Stock News

Remus Pharmaceuticals Ltd FAQs

The current trading price of Remus Pharmaceutical on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Remus Pharmaceutical stood at ₹789.7.
The latest P/E ratio of Remus Pharmaceutical as of 31-Dec-1969 is 39.68.
The latest P/B ratio of Remus Pharmaceutical as of 31-Dec-1969 is 3.18.
The 52-week high of Remus Pharmaceutical is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Remus Pharmaceutical is ₹79.16 ( Cr.) .

About Remus Pharmaceuticals Ltd

The company was originally incorporated as ‘Remus Pharmaceuticals Private Limited’ as a private limited company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Later on, pursuant to a special resolution passed by its shareholders in the Extra-Ordinary General Meeting held on January 02, 2023, the company was converted from a private limited company to public limited company and consequently, the name of the company was changed to ‘Remus Pharmaceuticals Limited’, and a fresh certificate of incorporation dated January 06, 2023 was issued to the company by the Registrar of Companies, Ahmedabad. 

The company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Having cultivated strong and dependable customer relationships ranging from Generic distributors, regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network, its clients are spread in various countries. It looks forward to form long lasting relationships that enhance the lives of its patients.

The company is majorly engrossed in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical finished formulations and products. Depending upon business requirements, it gets finished pharmaceutical formulations manufactured on loan license or contract manufacturing. Such manufacturing is on principle to principle basis. It has its presence through registered and/or under registration products in countries namely Bhutan, Bolivia, Chile, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong Kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, Vietnam etc. It deals in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

Business area of the company

The company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient).

Products of the company

  • Cardiovascular
  • Anti-DIABETIC
  • Central nervous system
  • Analgesic / Anti-Inflammatory
  • Anti-Allergy
  • Anti-Infective / Anti biotics 
  • Hormonal
  • Urology
  • Immuno suppressant
  • Erectile dysfunction
  • Effervescent
  • Other formulations

History and milestones

  • 2015: The company was incorporated as a private limited company under the name ‘Remus Pharmaceuticals Private Limited’.
  • 2023: Conversion of the company from Private Limited to Public Limited Company.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×